Their collective journey extends decades of impact from: working on HER2/neu test for breast cancer, the inception of Bioinformatics, creation of bioinformatics business units into pharma, development of OWL semantic web languages, moving molecular modeling from academics to commercial opportunities, adoption of computer graphics in drug design, forefront introduction of NLP technologies for practical applications, adoption of semantic technologies (NLP and other), statin wars, industry's shift from blockbuster's in metabolic syndrome to targeted personalized medicine, digital health technologies, Affordable Care Act, concept of moving EHRs to PHRs extending office visit to patient ecosystem, commoditization of healthcare data, oncologic value based care-era......to current synthetic clinical trials and RWE to support label extensions...Along with the raw experiences of being patients in the system. These elements help inform and sculpt the unique and un-paralled approach that IPQ offers.
We came together, united by focusing on problem discovery before solution validation. Through our complementary skill sets spanning scientific, technical and commercial domains within more than 20+ diseases and conditions, we drive results going beyond addressing 'unmet clinical needs' to identify and address 'unstated, unmet clinical needs.' This requires us working closely with clinicians, patients and pharma/diagnostic groups, nationally and internationally, approaching the problem as the deep immersion into specific diseases and conditions combined with a careful abstraction to develop analytic methods and models that are disease-agnostic.
IPQ’s multi-disciplinary, leadership team, represents more than 100 years of experience in academia and industry (pharma, diagnostics, healthcare, and technology in both large corporations and startups) spanning companies such as: Abbott, Wyeth, GSK, Merck, UPenn Cancer Center, Drexel University College of Medicine, First Hospital of Wenzhou Medical University (China), University California Irvine Medical Center, American College of Healthcare Executives, Phoenix Institute of Herbal Medicine & Acupuncture, to software and data vendors such as: Data2Discovery, Integra Connect, and Verana Health.
Established in 2011, IPQ Analytics has been a leader in the development and application of novel solutions to healthcare and the life sciences for decades. As a digital healthcare modeling and analytics company, IPQ converts data into knowledge to extract insights from the complexities that exist within real-world healthcare. By applying proprietary Next Generation Phenotyping (NGP), IPQ enables customers with a deep understanding of the patient's clinical journey to discover new insights via private and public data. Through collaborative partnerships, novel approaches, and advanced technologies, IPQ Analytics provides the information needed for critical decision making in healthcare and life sciences.
Intelligent-integration of disparate data sources builds the real-world experience, culiminating in actionable visuals. No longer must data sit siloed and in-actioned. The future patients and effective treatments are present. IPQ Analytics experienced team and high-performance technology enables the imagination to be stretched.
Are you seeking to validate or discover? Our team of experts can help illumate your inquiry path enabling high-specifity fit-for-purpose refinement.
Copyright © 2011 IPQ Analytics - All Rights Reserved. Website Designed + Built by: Angela Arhontes